Researchers have reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
from Latest Science News -- ScienceDaily https://ift.tt/2OEPyyD
via IFTTT
Sunday, December 1, 2019
Hydromethylthionine could slow cognitive decline: Minimum dose
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment